Fluorescence-based immunosensors
serve a vital role in biotechnology
and diagnostic and therapeutic applications. Our group recently developed
a unique fluoroimmunosensor named Quenchbody (Q-body) that operates
based on the principle of quenching and the antigen-dependent release
of fluorophore, which is incorporated to a recombinant antibody fragment,
either the single-chain Fv (scFv) or the Fab fragment of an antibody,
using a cell-free transcription-translation system. With the objective
of extending the functionality and diversity of the Q-body, here we
attempted to make Q-bodies by labeling the recombinant scFv, which
was prepared from E. coli using several
commercially available dye-maleimides. As a result, we reproducibly
obtained larger amounts of antiosteocalcin Q-bodies, with an improved
yield and cost-efficiency compared with those obtained from a conventional
cell-free system. The fluorescence intensity of each Q-body, including
that labeled with newly tested rhodamine red, was significantly increased
in the presence of an antigen with a low detection limit, although
some differences in response were observed for the dye with different
spacer lengths between dye and maleimide. The results indicate the
Q-body’s applicability as a powerful multicolored sensor, with
a potential to simultaneously monitor multiple targets in a sample.